Surface antigen
Showing 1 - 25 of 7,180
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)
Not yet recruiting
- Resolved Hepatitis B
- CD20 Positive B-cell Lymphoma
- (no location specified)
Jul 10, 2022
Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,
Active, not recruiting
- Malignant Pleural Disease
- +4 more
- iCasp9M28z T cell infusions
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 14, 2022
Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)
Recruiting
- Chronic Hepatitis B
- continuous treatment
- pulse therapy
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 13, 2022
Chronic Hepatitis B Trial in Melbourne (162, Placebo)
Recruiting
- Chronic Hepatitis B
- 162
- Placebo
-
Melbourne, AustraliaNucleus Network Pty Ltd
Jun 5, 2022
SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)
Not yet recruiting
- SARS CoV 2 Infection
- Influenza, Human
- BIMERVAX
- SIIV
-
Santiago De Compostela, A Coruña, Spain
- +7 more
Aug 8, 2023
Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])
Withdrawn
- Hepatitis B
- Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
-
Baltimore, Maryland
- +1 more
Jul 19, 2022
Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine
Recruiting
- Hepatitis B
- GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
- +4 more
-
Cambridge, United KingdomGSK Investigational Site
Jan 12, 2023
Seasonal Influenza Trial in Germany (Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011)
Completed
- Seasonal Influenza
- Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011
-
Germany, GermanyNovartis Investigational Site
Mar 9, 2021
Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)
Completed
- Chronic Hepatitis B
- PegIFN α- 2b
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 11, 2022
Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)
Recruiting
- Hepatitis B, Chronic
- pegylated interferon-alfa
-
Guangzhou, Guangdong, ChinaDepartment of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021
Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)
Not yet recruiting
- Breast Neoplasm
- +9 more
- Dalpiciclib
- +15 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022
Australian Hepatitis and Risk Survey in Prisons
Recruiting
- Hepatitis C
- +2 more
- Point-of-care hepatitis C antibody test
- +5 more
-
Hume, Australian Capital Territory, Australia
- +23 more
Apr 20, 2023
Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))
Withdrawn
- Hepatitis B, Chronic
- Entecavir (ETV)
- +2 more
-
Kolding, Denmark
- +29 more
Oct 27, 2022
ESRD, Influenza Vaccine, Seroprotection Trial in Ratchathewi (Egg-derived standard dose trivalent influenza vaccine (surface
Recruiting
- ESRD
- +2 more
- Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
-
Ratchathewi, ฺBangkok, ThailandAngsana Phuphuakrat
Nov 1, 2021
Cirrhosis, Liver, Vaccination Failure, HBV Trial (IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN)
Not yet recruiting
- Cirrhosis, Liver
- +3 more
- IMIQUIMOD cream
- HEPATITIS B SURFACE ANTIGEN
- (no location specified)
Aug 27, 2021
Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir
Completed
- Chronic Hepatitis B
- Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Mar 25, 2021
Chronic Hepatitis b Trial in Taipei (Spirulina)
Completed
- Chronic Hepatitis b
- Spirulina
-
Taipei, Wenshan District, TaiwanWanfang Hospital
Jan 20, 2021
Malaria Trial in Silver Spring (Mefloquine, Control)
Completed
- Malaria
- Mefloquine
- Control
-
Silver Spring, MarylandWalter Reed Army Institute of Research
Apr 14, 2021
Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),
Completed
- Influenza
- High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
- +4 more
-
San Diego, California
- +15 more
Mar 24, 2022
Chronic Hepatitis B Trial in Hong Kong (Treatment cessation)
Completed
- Chronic Hepatitis B
- Treatment cessation
-
Hong Kong, Hong KongDepartment of Medicine, The University of Hong Kong, Queen Mary
Feb 6, 2020
Hepatitis D Virus Infection Among Hepatitis B Virus Surface
Completed
- HDV Infection
- HBV Infection
- (no location specified)
Jul 27, 2019
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)
Recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Vancouver, British Columbia, Canada
- +31 more
Jan 17, 2023
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)
Active, not recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Edegem, Belgium
- +12 more
Jan 17, 2023
Hepatitis C, Chronic Trial (HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests, DAAs)
Completed
- Hepatitis C, Chronic
- HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests
- DAAs
- (no location specified)
Nov 22, 2019